The problem with blaming everything on inflammation
Chronic inflammation is a modern health problem — one that too many wellness influencers oversimplify. Inflammation is on everybody’s minds these days, and it seems like wherever you look, someone is telling you how to reduce your inflammation, from influencers on your TikTok feed or Instagram reels to even US Health Secretary Robert F. Kennedy Jr. […]
Brave new world: Making pizzas in the era of the GLP-1 phenomenon
IJMS, Vol. 27, Pages 627: KBN2202 Suppresses Gonadal White Adipose Tissue Expansion in Female Mice Fed a High-Fat Diet
IJMS, Vol. 27, Pages 627: KBN2202 Suppresses Gonadal White Adipose Tissue Expansion in Female Mice Fed a High-Fat Diet International Journal of Molecular Sciences doi: 10.3390/ijms27020627 Authors: Moonhang Kim Jeong-Hyeon Heo Seok Hwan Chang Sun-Young Lee Jihun Kim Moon-Geun Shin Jong Sung Kim Mi Ran Choi Sang-Rae Lee Obesity treatments increasingly target multiple pathways beyond […]
Top Insulin Expert: Insulin Is More Dangerous Than Sugar! This Will Strip Fat Faster Than Anything!
No.1 Health Doctor Benjamin Bikman breaks down keto, insulin resistance, sugar addiction, and calorie counting, and the ONE test that predicts weight gain! Dr Benjamin Bikman is a metabolic scientist and researcher focused on the link between insulin resistance and chronic disease. He is Professor of Cell Biology at Brigham Young University and Co-founder of […]
Nutrition Strategies for Next‐Generation Incretin Therapies: A Systematic Scoping Review of the Current Evidence
ABSTRACT Next-generation incretin therapies, including semaglutide and tirzepatide, have transformed obesity and Type 2 diabetes management. However, evidence-based nutritional strategies to support safe and effective use of these agents remain limited. To address this gap, we conducted a systematic scoping review across five databases of studies published between January 2015 and April 2025 to map […]
Study highlights prevalence of GLP-1/GIP medication use for weight loss in UK
In early 2025, around 4.9 million British adults – almost one in ten – are estimated to have recently used, or expressed interest in using, glucagon-like peptide-1 (GLP-1) or dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist medications to support weight loss. The findings, which are based on a nationally representative household survey of 5,260 British […]
The Executive Briefing: Saks in Crisis; The Battle for Lululemon; A Holiday Shopping Miracle
America’s largest department store operator is on the brink, Lululemon’s founder is making moves and GLP-1 pills promise to shake up fashion this year. Read on for your concise breakdown of November’s key developments from executive editor Brian Baskin.
Thursday briefing: Why skinny jabs’ short-term fix comes with long-term concerns
In today’s newsletter: A new study shows that people don’t just regain weight after stopping GLP-1 drugs, they see other positive health markers reverse – leading to questions about long-term impacts and solutions Good morning. If you are as chronically online as I am, you have probably noticed a major shift by some of your […]
Brain Stimulation Matches Semaglutide for Weight Loss
In a retrospective study, repetitive transcranial magnetic stimulation produces weight loss comparable to semaglutide 0.5 mg/wk in patients with obesity and type 2 diabetes. Medscape Medical News
Thai FDA seeks to tighten controls on GLP-1 ‘slimming pens’, proposing special controlled-drug status
The move will limit sales to pharmacies with a doctor’s prescription amid misuse online.